期刊文献+

无血清培养基SYL-SF对间充质干细胞的培养和扩增作用 被引量:2

Culture and expansion of mesenchymal stem cells by serum free medium
暂未订购
导出
摘要 目的 探讨新型无血清培养基SYL—SF对脐带间充质干细胞的体外培养和扩增作用。方法机械分离方法获得脐带间充质干细胞,从P1代开始将含小牛血清的原代培养基SYL-NBCS更换为实验组SYL-SF和对照组MSCM-SF两种无血清培养基对细胞进行培养、传代、扩增和维持。利用Alexa Fluor 488 annexin V检测细胞凋亡率,CCK-8法比较传代细胞的增殖效率,并对细胞进行形态、表型、染色体核型和分化能力等方面的检测和评价。结果分离得到的单个脐带问充质干细胞在原代培养基SYL-NBCS中培养8-15d可获得原代(P0)细胞,更换为无血清培养基后,SYL-SF组细胞凋亡率明显低于MSCM-SF组;在细胞传代过程中SYL—SF组细胞增殖能力较强且维持MSCs特异性表面标志和向脂肪、骨、软骨等多向分化的潜能,并且在传代过程中维持正常染色体核型。结论SYL—SF无血清培养基可以对UC-MSCs进行良好地体外扩增和维持。 Objective To investigate the effect of a new serum-free medium SYL-SF on the culture and expansion of umbilical cord derived mesenchymal stem ceils (UC-MSCs). Methods UC-MSCs were obtained from aborted human umbilical cord by mechanical isolation method, and were maintained in primary culture medium SYL-NBCS. From passage 1 (P1), UC-MSCs were maintained and expanded in two different types of serum-free medium SYL-SF and MSCM-SF. Apoptosis was analyzed with Alexa Fluor 488 annexin V apotosis kit and cellular proliferation was analyzed with CCK-8 method. Cellular morphology, karyotype, cell surface marker and differentiation capacity were also detected. Results Primary UC-MSCs (P0) are obtained 8 to 15 days after the mechanical isolation and cultured in primary medium SYL-NBCS. When the cells are changed into serum-free medium, the apoptosis rate of the cells cultured in SYL-SF is significantly lower than those in MSCM-SF. In SYL-SF medium, UC-MSCs expend faster and maintain MSCs-specific surface markers as well as the multipotent differentiation potential towards fat, bone and cartilage. They also maintain normal karyotype after 8 passages of culture in SYL-SF. Conclusion SYL-SF as a novel serum-free medium can be used to support the expansion and maintenance of UC-MSCs in vitro.
出处 《中国医药生物技术》 CSCD 2012年第5期321-326,共6页 Chinese Medicinal Biotechnology
关键词 间质干细胞 培养基 无血清 生物疗法 蛋白质类 Mesenchymal stem cells Culture media, serum-free Biological therapy Proteins
  • 相关文献

参考文献10

  • 1Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenehymal stem cells. Science, 1999, 284(5411):143- 147.
  • 2Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005, 105(4): 1815-1822.
  • 3Xu Y, Meng H, Li C, et al. Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revaseularization. Stem Cells Dev, 2010, 19(10):1511-1522.
  • 4Koc ON, Peters C, Aubourg P, et al. Bone marrow derived mesenchymal stem cells remain host derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol, 1999,27(11):1675-1681.
  • 5Yannaki E, Anagnostopoulos A, Kapetanos D, et al. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells Exo Hematol, 2006, 34(11):1583-1587.
  • 6Kuo TK, Hung SP, Chuang CH, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology, 134(7):2111-2121.
  • 7Hass R, Kasper C, Bohm S, et al. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Comrnun Signal, 2011, 9:12.
  • 8方彦艳,马健.无血清培养基分离培养脐带间充质干细胞的研究[J].同济大学学报(医学版),2010,31(5):21-24. 被引量:4
  • 9Sarugaser R, Lickorish D, Baksh D, et al. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitor. Stem Cells, 2005, 23(2):220-229.
  • 10Furge KA, Zhang YW, Vande Woude GF. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene, 2000, 19(49): 5582-5589.

二级参考文献8

  • 1Hwang JH,Shim SS,Seok OS,et al.Comparison of cytokine expression in mesenchymal stem cells from human placenta,cord blood,and bone marrow[J].J Korean Med Sci,2009,24(4):547-554.
  • 2Hattori H,Ishihara M,Fukuda T,et al.Establishment of a novel method for enriching osteoblast progenitors from adipose tissues using a difference in cell adhesive properties[J].Biochem Biophys Res Commun,2006,343(4):1118-1123.
  • 3Zhou S,Greenberger JS,Epperly MW,et al.Agerelated intrinsic changes in human bone marrow-derived mesenchymal stem cells and their differentiation to osteoblasts[J].Aging Cell,2008,7(3):335-343.
  • 4Girdlestone J,Limbani VA,Curler A J,et al.Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions[J].Cytotherapy,2009,11(6):738-748.
  • 5Samgaser R,Lickorish D,Baksh D,et al.Human umbilical cord perivascular (HUCPV) cells:a source of mesenchymal progenitors[J].Stem Cells,2005,23 (2):220-229.
  • 6Baksh D,Yao R,Tuan RS.Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow[J].Stem Cells,2007,25(6):1384-1392.
  • 7张丽,张俊杰,林永辉,葛艳丽,杨行堂,王志荣.大鼠骨髓间质干细胞的体外分离培养及初步鉴定[J].同济大学学报(医学版),2009,30(1):32-35. 被引量:5
  • 8徐燕,李长虹,孟恒星,郝牧,邱录贵.人脐带间充质干细胞分离培养条件的优化及其生物学特性[J].中国组织工程研究与临床康复,2009,13(32):6289-6294. 被引量:38

共引文献3

同被引文献40

  • 1Mannello F, Tonti GA. Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free medium with fetal calf serum, human serum, or enriched plasma serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold[ [J]. Stem Cells, 2007, 25(7): 1603-1609.
  • 2Sadan O, Melamed E, Offen D. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative dis- eases [J]. Expert Opin Biol Ther, 2009, 9(12): 1487-1497.
  • 3Bernardo ME, Pagliara D, Locatelli F. Mesenchymal stro- mal cell therapy: a revolution in Regenerative Medicine? [J]. Bone Marrow Transplant, 2012, 47(2): 164-171.
  • 4Sanz AR, Carri 6 n FS, Chaparro AP. Mesenchymal stem cells from the oral cavity and their potential value in tissue engineering[J]. Periodontol2000, 2015, 67(1): 251-267.
  • 5Han J, Menicanin D, Marino V, et al. Assessment of the regenerative potential of allogeneic periodontal ligament stem cells in a rodent periodontal defect model [J]. J Periodontal Res, 2014, 49(3): 333-345.
  • 6Seo BM, Miura M, Gronthos S, et al. Investigation of mul- tipotent postnatal stem cells from human periodontal ligament [J]. Lancet, 2004, 364(9429): 149-155.
  • 7Berger MG, Veyrat-Masson R, Rapatel C, et al. Cell cul- ture medium composition and translational adult bone mar- row-derived stem cell research[J]. Stem Cells, 2006, 24(12): 2888-2890.
  • 8Shahdadfar A, Fr?nsdal K, Hang T, et al. In vitro expan- sion of human mesenchymal stem ceils: choice of serum is a determinant of cell proliferation, differentiation, gene ex- pression, and transcriptome stability [J]. Stem Cells, 2005, 23(9): 1357-1366.
  • 9Satija NK, Gurudutta GU, Sharma S, et al. Mesenchymal stem cells: Molecular targets for tissue engineering [J]. Stem CellsDev, 2007, 16:7-23.
  • 10Price P J, Gregory EA. Relationship between in vitro growth promotion and biophysical and biochemical properties of the serumsupplement[J]. InVitro, 1982, 18:576-584.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部